Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

61 results about "Transcription initiation site" patented technology

Controllable genome-modified plasmodium, recombinant expression vector and construction method and application of controllable genome-modified plasmodium and recombinant expression vector

The invention relates to a controllable genome-modified plasmodium, a recombinant expression vector and the construction method and application of the controllable genome-modified plasmodium and the recombinant expression vector. The recombinant expression vector comprises a gene targeting long homologous arm, a gene targeting short homologous arm, a tetracycline repression protein gene expression cassette, a pyrimethamine resistance gene expression cassette and a target gene expression cassette, wherein the tetracycline repression protein gene expression cassette, the pyrimethamine resistance gene expression cassette and the target gene expression cassette are located between the gene targeting long homologous arm and the gene targeting short homologous arm, and tetracycline operator gene sequences are inserted in multiple transcriptional start sites of a target gene promoter, so that the recombinant expression vector can be used for conditional research of the functions of a certain functional gene in a plasmodium genome. Furthermore, a functional gene expression sequence, corresponding to a target gene, in the plasmodium genome is knocked out by means of the gene knockout technique; meanwhile, the recombinant expression vector is transfected into a plasmodium with genes knocked out, so that the controllable genome-modified plasmodium is obtained; a new technical scheme is provided for further research of the functions of all functional genes in the plasmodium genome, and application prospects are broad.
Owner:GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI

Small molecule RNA, preparation method thereof and application in pharmaceuticals for transcriptional activity of specificity up-regulated genes

The invention discloses a method for specificity up-regulated gene expression through a targeting core promoter utilizing small molecule RNAs (including micro-RNAs and small interfering RNAs) and a series of regulation target genes. According to the invention, when a TATAbox sequence is contained in the promoter, a target site is in the range of expanding 20 basic groups from the upstream and downstream sides respectively by taking the TATAbox sequence as the center; when no TATAbox sequence is contained in the promoter, the target site is a 1-50 sequences on the upstream side of the genetic transcription initiation site. The micro-RNAs hsa-let-7i, hsa-miR-138, hsa-miR-92a, hsa-let-7c and hsa-miR-181d specifically regulate up the expression of interleukin-2, insulin, thyrocalcitonin, histone and c-myc gene respectively. Besides, aiming to the randomly-selected 19 gene promoters, the artificially-synthesized small interfering RNAs (siRNAs) can enhance the transcriptional activities of 78.9% of the genes. The invention aims to provide the method for specificity up-regulated gene expression utilizing micro-RNAs and has higher application values and broad application prospects in the biotechnology and the biomedicine field.
Owner:GUANGZHOU QIANYANG BIO-TECH PHARM CO LTD

Library construction method capable of detecting transcription initiation sites of eukaryotes by using high-throughput sequencing technology

The invention belongs to the technical field of molecular biology, and particularly relates to a library construction method capable of detecting poly (A) RNA transcription initiation sites of eukaryotes by using a high-throughput sequencing technology. The method is used for RNA with poly (A) tail and cap structure in the eukaryotes, and comprises the following steps: purifying to obtain the poly(A) RNA, removing phosphorylation, removing the cap structure, connecting RNA adapter, carrying out reverse transcription, carrying out PCR amplification, carrying out enzyme digestion, connecting double-stranded DNA adapter, carrying out PCR enrichment transcription initiation sites library, carrying out purification and analysis of the library. The method has the advantages of high cap removalefficiency, capability of efficiently constructing a transcription initiation sites library, convenience for accurately positioning the transcription initiation sites, simplicity and convenience in sequencing method, contribution to improving the accuracy of a transcription initiation sites analysis result and the like; the technique can be used for the study of all RNA transcription initiation sites with the cap structure with a slight improvement.
Owner:HENAN NORMAL UNIV

Model for predicting gestational diabetes mellitus by using peripheral blood free DNA

ActiveCN110387414AEffectively predict the onsetEasy to combineMicrobiological testing/measurementSequence analysisTranscription initiation siteNeonatal diabetes
The invention discloses a model for predicting gestational diabetes mellitus by using peripheral blood free DNA. According to research finding of the model, distribution of the peripheral blood free DNA in the region of a gene transcription initiation site can reflect the physiological status of pregnant women and fetuses, after the free DNA abundance is subjected to homogenization correction based on the fact that the serum free DNA abundance in the region of the gene transcription initiation site has the significant difference between gestational diabetes patients and healthy pregnant women,a machine learning algorithm is used, and optimal combination of different differential genes can effectively predict the incidence of gestational diabetes; and thus a screening prediction model forgestational diabetes based on peripheral blood free DNA prediction and an optimized combination of target genes are constructed, the incidence of gestational diabetes can be predicted before the onsetof the clinical symptoms of gestational diabetes, a relatively non-invasive, economical and convenient method for predicting early gestational diabetes is achieved, and good application prospects indeveloping predictive screening products for gestational diabetes are achieved.
Owner:GUANGZHOU DARUI BIOTECH

Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences

The present invention relates to expression vectors for the heterologous expression of a nucleic acid sequence of interest in mammalian cells, the vectors comprising a chimeric promoter regulatory sequence being operably linked to a nucleic acid sequence to be expressed, wherein the chimeric promoter regulatory sequence comprises a cytomegalovirus promoter sequence derived from murine cytomegalovirus or from human cytomegalovirus and being operably linked to the transcriptional start site of the nucleic acid sequence to be expressed; and a cytomegalovirus upstream region and/or enhancer sequence derived from human and/or the simian cytomegalovirus, wherein the upstream region and/or enhancer sequence is located 5′ of and operably linked to the murine or the human promoter sequence, and wherein the chimeric promoter regulatory sequence comprises sequence elements being derived from at least two of the group consisting of murine cytomegalovirus, human cytomegalovirus and simian cytomegalovirus. In particular embodiments, the chimeric promoter regulatory sequence comprises sequence elements derived from the murine or the human cytomegalovirus IE1 promoter and from the human and/or the simian cytomegalovirus IE1 region. The invention also relates to mammalian host cells transfected with such expression vectors, a method for heterologous expression of a nucleic acid sequence in a mammalian host cell by employing such expression vectors, and the use of such expression vectors for the heterologous expression of a nucleic acid sequence.
Owner:LONZA BIOLOGICS PLC

Detection method for capturing cfDNA5mC fragment

The invention discloses a detection method for capturing a cfDNA5mC fragment. The detection method comprises the following steps: step 1, preparing reagents; step 2, preparing Inculation Mix, and operating at the temperature of 4 DEG C; step 3, diluting an Antibody at 1: 15, placing the antibody at -80 DEG C, adding 0.5 [mu] l of the antibody and 7.5 [mu] l of H2O (excess), and timely placing the antibody at-80 DEG C after the antibody is used up; step 4, preparation of Antibody Mix: the Antibody Mix is excessive, and three amounts of Antibody Mix are generally prepared for two samples; step 5, mixing an Inculation Mix and the Antibody Mix, rotating at the rotating speed of 40 at the temperature of 4 DEG C, and incubating overnight for 17 hours; and step 6, preparing an Ipre Kit v2 reagent. According to the detection method for capturing the cfDNA5mC fragment, methylation of fifth carbon of cytosine (5-methylcytosine: 5mC) is a methylation type excavated in eukaryotes at the earliest, in gene expression, a transcription start site region is generally non-methylated, and when the gene is expressed at a lower level, the methylation level of cytosine in a regulation region is higher, and library correlation generated by different initial quantities and different methods is an effective parameter for evaluating consistency and high performance.
Owner:深圳泰莱生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products